Dremenia Homecare L
€15,990.00
Hyperbaric oxygen therapy for home use
Experience the benefits of hyperbaric oxygen therapy (HBO, HBOT) in the comfort of your own home.
With Dremenia Homecare L, you can enjoy therapy without waiting lists, travel times, or fixed appointments – flexible, comfortable, and cost-effective.
The Homecare L was specifically designed for home use. With a large diameter of 80 cm, the chamber is also suitable for use in combination with a patient hoist, offering maximum comfort.
For users who prefer to treat while sitting , we recommend the model:
Dremenia Comfort – barrier-free oxygen therapy while sitting.
Home application instead of waiting room
Based on current studies and research findings , HBOT application at home can support significant progress in various health conditions, such as:
Long Covid & chronic fatigue (CFS)
COPD & respiratory diseases
Parkinson
Vaccination consequences
Diabetes & poorly healing wounds (e.g. pressure ulcers)
Fibromyalgia
Sudden hearing loss, ringing in the ears & tinnitus
Bone and joint problems (e.g. osteonecrosis, bone marrow edema)
Lyme disease
Autism & ADHD
Late effects after radiotherapy
Technical data
| feature | Details |
|---|---|
| Operating pressure | 1.3 or 1.5 bar |
| diameter | 800 mm |
| length | 2100 mm |
| Weight chamber | approx. 95 kg |
| material | Thermoplastic urethane (extra strong) |
| Pressure control valves | 2 pieces, automatic |
| Emergency valve | 1 piece |
| upholstery | Latex mattress |
| Subframe/entry | stainless steel, external |
| compressor | 70 l/min air flow, <55 dB |
| supply unit | 365 × 375 × 600 mm |
| air cooler | 150 l/min |
| oxygen concentrator | 1–10 l/min, up to 96% purity |
| Color | Standard white or blue, optional protective cover in 25 colors |
Dremenia – milde Überdruckkammern sind kein Medizinprodukt im Sinne der Verordnung (EU) 2017/745 des Europäischen Parlaments und des Rates vom 5. April 2017 über Medizinprodukte, zur Änderung der Richtlinie 2001/83/EG, der Verordnung (EG) Nr. 178/2002 und der Verordnung (EG) Nr. 1223/2009 und zur Aufhebung der Richtlinien 90/385/EWG und 93/42/EWG des Rates. Insbesondere werden sie nicht verwendet für: Diagnose, Prävention, Überwachung, Vorhersage, Prognose, Behandlung oder Linderung von Krankheiten, Verletzungen oder Behinderungen, einschließlich der Entschädigung für Verletzungen oder Behinderungen.








